Novan (NOVN) Stock Price & Analysis

NOVN Stock Chart & Stats

$0.07-$0.02(-22.34%)

At close: Jul 26 4:00 PM EDT

Day’s Range: $0.03 - $0.09
52-Week Range: $0.03 - $3.33
Previous Close: $0.09
Volume: N/A
Average Volume (3M): 2.18M
Market Cap: $28
Enterprise Value: $25.50M
Total Cash (Recent Filing): $12.54M
Total Debt (Recent Filing): $3.85M
Price to Earnings (P/E): ―
Beta: N/A
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Novan News

Novan Inc Emerges from Bankruptcy, Cancels Equity

The latest update is out from Novan Inc (NOVN). NVN Liquidation, Inc., formerly known as Novan, Inc., and its subsidiary, EPI Health, LLC, have successfully navigated Chapter 11 bankruptcy with

2y ago8K NOVN

Novan Inc Announces Chapter 11 Bankruptcy Progress

Novan Inc (NOVN) just unveiled an announcement. NVN Liquidation, Inc., formerly Novan, Inc., and its subsidiary EPI Health, LLC, entered Chapter 11 bankruptcy in July 2023, with their liquidation plan

2y ago8K NOVN

Novan Inc’s Chapter 11 Bankruptcy and Liquidation Plan

Novan Inc (NOVN) has shared an update. NVN Liquidation, Inc., formerly known as Novan, Inc., and its subsidiary EPI Health have entered Chapter 11 bankruptcy, with a liquidation plan confirmed

2y ago8K NOVN

Novan Inc Announces Chapter 11 Bankruptcy Confirmation

Novan Inc (NOVN) has released an update to notify the public and investors about its debt resolution strategies. On July 17, 2023, NVN Liquidation, Inc. and its subsidiary EPI Health

2y ago8K NOVN

Novan Inc Warns Against Stock Trading Post-Bankruptcy Filing

Novan Inc (NOVN) has released an update to notify the public and investors about a regulation fd disclosure. NVN Liquidation, Inc. and its subsidiary, EPI Health, LLC, filed for Chapter

2y ago8K NOVN

Three option delistings on July 27th

Option delistings effective July 27th include Novan Inc (NOVN), 9 Meters Biopharma Inc (NMTR), and Viewray Inc (VRAY). Published first on TheFly – the ultimate source for real-time, market-moving breaking

3y agoNOVN 6LUA

Novan trading resumes

09:15 EDT Novan trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More

3y agoNOVN 6LUA

Ligand offers to acquire Novan for $15M in cash, $15M in financing

Ligand (LGND) announced that it has made an offer to acquire the assets of Novan (NOVN) for $15M in cash and provide up to $15M in DIP financing to Novan

3y agoLGND NOVN

Novan to sell substantially all assets for $15M, files for Chapter 11 protection

Novan (NOVN) and its wholly owned subsidiary, EPI Health entered into a stalking horse asset purchase agreement with Ligand Pharmaceuticals (LGND) prior to filing voluntary petitions for relief under chapter

3y agoLGND NOVN

Novan trading halted, news pending

08:13 EDT Novan trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts

3y agoNOVN 6LUA

Novan downgraded to Hold from Buy at Brookline

Brookline analyst Kemp Dolliver downgraded Novan to Hold from Buy. Published first on TheFly See the top stocks recommended by analysts >> Read More on NOVN: Novan to Provide Corporate

3y agoNOVN 6LUA

Novan Inc (NOVN) Q1 Earnings Cheat Sheet

Novan Inc (NOVN) is scheduled to report 1st quarter earnings on 05/16/2023. Regarding Q1 estimates, Wall Street analysts expect Novan Inc to post earnings of -$0.32 per share. Revenue expectations

3y agoNOVN 6LUA

Novan announces publication of psoriasis patient data

Novan and MC2 Therapeutics announced that results of a recently conducted survey to assess psoriasis patients’ topical treatment experience, expectations, and preferences have been published in the Journal of Drugs

3y agoNOVN 6LUA

Biotech Alert: Searches spiking for these stocks today

Stay ahead of biotech stocks seeing a surge in interest from retail and financial professional investors with this exclusive recap from The Fly These names in the biotech sector are

3y agoNBY EYPT

NOVN FAQ

What was Novan’s price range in the past 12 months?

Novan lowest stock price was $0.03 and its highest was $3.33 in the past 12 months.

What is Novan’s market cap?

Novan’s market cap is $28.

When is Novan’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is Novan overvalued?

According to Wall Street analysts Novan’s price is currently Undervalued.

Does Novan pay dividends?

Novan does not currently pay dividends.

What is Novan’s EPS estimate?

Novan’s EPS estimate for its next earnings report is not yet available.

Which hedge fund is a major shareholder of Novan?

Currently, no hedge funds are holding shares in NOVN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Novan

Novan, Inc. operates as a pre-commercial pharmaceutical entity specializing in nitric oxide-derived therapies for dermatological and anti-infective conditions. The company boasts a robust clinical-stage pipeline featuring several topical drug candidates. For skin-related ailments, these include SB204, a monotherapy aimed at acne vulgaris; SB206, an antiviral gel targeting viral skin infections; SB208, a broad-spectrum antifungal gel designed to combat various fungal skin and nail infections like athlete's foot; and SB414, a cream-based gel formulated for inflammatory skin diseases. Additionally, Novan is advancing SB207 to treat external genital warts, WH602 (an intravaginal gel) and WH504 (a non-gel formulation) both addressing high-risk human papillomavirus (HPV), and SB019, a candidate for SARS-CoV-2. The firm has cultivated strategic partnerships, holding a licensing agreement with Sato Pharmaceutical Co., Ltd., and engaging in a strategic alliance with Orion Corporation. Founded in 2006, Novan, Inc. maintains its headquarters in Durham, North Carolina.

Novan (NOVN) Earnings & Revenues

Historic Earnings Reports

NOVN Stock 12 Month Forecast

Average Price Target

$153.68▲(210418.22% Upside)

Past 12 Months12 Month ForecastOct2022Jul2023

High$156.69

Average$153.68

Low$150.67

Detailed Analyst Forecast >

Similar Stocks

Stocks similar to NOVN
Company	Price & Change	Follow
EYPTEyePoint Pharmaceuticals
HURATuHURA Biosciences
OGENOragenics
INSMInsmed
CPIXCumberland Pharmaceuticals

Compare NOVN Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

NOVN Stock Chart & Stats

Novan News

Novan Inc Emerges from Bankruptcy, Cancels Equity

Novan Inc Announces Chapter 11 Bankruptcy Progress

Novan Inc’s Chapter 11 Bankruptcy and Liquidation Plan

Novan Inc Announces Chapter 11 Bankruptcy Confirmation

Novan Inc Warns Against Stock Trading Post-Bankruptcy Filing

Three option delistings on July 27th

Novan trading resumes

Ligand offers to acquire Novan for $15M in cash, $15M in financing

Novan to sell substantially all assets for $15M, files for Chapter 11 protection

Novan trading halted, news pending

Novan downgraded to Hold from Buy at Brookline

Novan Inc (NOVN) Q1 Earnings Cheat Sheet

Novan announces publication of psoriasis patient data

Biotech Alert: Searches spiking for these stocks today

NOVN FAQ

Company Description

Novan

Novan (NOVN) Earnings & Revenues

NOVN Stock 12 Month Forecast

Average Price Target

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium